Join
Live feed
·
INSIDERFilingvia Quantisnow
Clovis Oncology Inc. logo

SEC Form 4: Harding Thomas C. converted options into 299 shares and sold $444 worth of shares (148 units at $3.00), increasing direct ownership by 3% to 5,395 units to satisfy tax liability

ByQuantisnow·Wall Street's wire, on your screen.
CLVS· Clovis Oncology Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CLVS (Clovis Oncology Inc.) and more on Quantisnow.

SEC Form 4: Harding Thomas C. converted options into 299 shares and sold $444 worth of shares (148 units at $3.00), increasing direct ownership by 3% to 5,395 units to satisfy tax liability | Quantisnow